Related Experiment Video
Updated: May 17, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
NPRL2 gene expression in the progression of colon tumors
B Yogurtcu1, I Hatemi, I Aydin
1Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Kocamustafapasa, Istanbul, Turkey.
Abstract:
Genetic and epigenetic factors affecting DNA methylation and gene expression are known to be involved in the development of colon cancer, but the full range of genetic alterations and many key genes involved in the pathogenesis of colon cancer remain to be identified. NPRL2 is a candidate tumor suppressor gene identified in the human chromosome 3p21.3 region. We evaluated the role of this gene in the pathogenesis of colorectal cancer by investigating NPRL2 mRNA expression in 55 matched normal and tumor colon tissue samples using quantitative RT-PCR analysis. There was significantly decreased NPRL2 expression in 45% of the patients. Lower NPRL2 expression was observed significantly more frequently in poorly differentiated tumor samples than in highly or moderately differentiated tumors. We conclude that expression of NPRL2 contributes to progression of colon cancer.
Insights
Reduced expression of the NPRL2 gene was observed in nearly half of colon cancer patients. Lower NPRL2 levels correlated with more aggressive tumors, suggesting its role in colon cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Genetic and epigenetic alterations, including DNA methylation and gene expression changes, are implicated in colon cancer development.
- Key genes driving colorectal cancer pathogenesis are not fully elucidated.
- NPRL2, a candidate tumor suppressor gene, is located on human chromosome 3p21.3.
Purpose of the Study:
- To investigate the role of the NPRL2 gene in colorectal cancer pathogenesis.
- To evaluate NPRL2 mRNA expression levels in matched normal and tumor colon tissues.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (RT-PCR) was employed.
- Analysis was performed on 55 pairs of matched normal and tumor colon tissue samples.
Main Results:
- Significantly decreased NPRL2 mRNA expression was detected in 45% of the colorectal cancer patients studied.
- Lower NPRL2 expression was significantly more frequent in poorly differentiated tumors compared to moderately or highly differentiated tumors.
- These findings indicate a correlation between reduced NPRL2 expression and tumor aggressiveness.
Conclusions:
- The study suggests that NPRL2 plays a role in the progression of colon cancer.
- Decreased NPRL2 expression may serve as a potential biomarker for more aggressive colorectal tumors.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
lncRNA - Long Non-coding RNAs
Abnormal Proliferation